Roche: shares dip after broker cuts target

(CercleFinance.com) - Shares in Swiss drugmaker Roche were the second-biggest faller on Zurich's blue chip index, the SMI, on Friday after UBS cuts its target price for the stock.


The private bank - which keeps a "buy" rating on the share - said it has reduced its target from 370 euros to 365 euros.

The Roche shares are currently down 0.8%, compared to a 0.3% drop for the SMI index.

Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.